Nasopharyngeal colonization and penicillin resistance among pneumococcal strains: a worldwide 2004 update

Déa M Cardozo1, Cristiana M C Nascimento-Carvalho, Fabiane R Souza

  • 1Department of Pediatrics, Faculty of Medicine, Federal University of Bahia, BA, Brazil.

Insights

Nasopharyngeal pneumococcus surveillance monitors antibiotic resistance. Colonization rates vary globally, with high rates in Africa but lower penicillin resistance, while Americas show higher resistance.

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Nasopharyngeal pneumococcus surveillance is crucial for tracking antibiotic resistance patterns.
  • Understanding colonization rates and resistance is vital for effective public health strategies.

Purpose of the Study:

  • To review and analyze global data on nasopharyngeal carriage of Streptococcus pneumoniae.
  • To assess current colonization rates and penicillin resistance trends worldwide.

Main Methods:

  • A comprehensive MEDLINE search was conducted using terms related to nasopharyngeal carriage and Streptococcus pneumoniae.
  • Data from 109 recent publications across 41 countries were analyzed.
  • Focus was on studies published between 1996-2003, analyzing colonization rates and penicillin resistance.

Main Results:

  • Highest pneumococcal colonization rates were observed in Africa (85-87.2%), with generally lower penicillin resistance.
  • North and Central America reported higher penicillin resistance rates (approx. 20-30%).
  • Significant variations in colonization and resistance were found within continents, regions, and even within countries.

Conclusions:

  • Global surveillance of nasopharyngeal pneumococcus reveals significant geographical variations in colonization and penicillin resistance.
  • Data gaps exist for many countries, hindering comprehensive global monitoring.
  • Antibiotic use for pneumococcal infections requires careful consideration in light of resistance patterns.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...